CDC panel recommends adding COVID-19 vaccines to regular immunizations
Thanumporn Thongkongkaew/iStock via Getty Images


An independent panel of experts at the Centers for Disease Control and Prevention (CDC) endorsed Thursday that COVID-19 vaccines should be added to the agencyâs regular immunizations recommended for children and adults.
CDCâs Advisory Committee on Immunization Practices (ACIP) voted in favor of the move, which will see COVID-19 vaccines becoming part of the regular immunizations such as measles and tetanus vaccines that U.S. adults and children aged six months and older are recommended to get.

CDC advisory committees issue non-binding recommendations. However, the federal agency usually follows them for a final decision.
If the CDC supports the decision, the agency is expected to publish the updated immunization schedules in February 2023.
The U.S. has authorized COVID-19 vaccines from Pfizer (NYSE:PFE)/ BioNTech (BNTX), Moderna (MRNA), Johnson & Johnson (JNJ), and Novavax (NVAX).
It is unclear how the decision will address vaccine hesitancy at a time when the U.S. plans to transition the COVID-19 vaccinations to the commercial market.